Intercell Logo
Header
  • for Investors
  • Stock Information
  • ADR Information
  • Shareholder Structure
  • Analysts
  • Annual General Meeting
  • Financial Calendar
  • Downloads
  • Corporate Governance
  • Investors Q&As
  • IR Contact
  • DEUTSCH
  • SITEMAP
  • Management
  • Corporate Social Responsibility
  • Directors' Dealings
  • Treasury Stock
  • Corporate Actions & Announcements
  • EUR 33.0 million Convertible Note 2011
  • GSK capital increase
  • Acquisition of Iomai Corporation
  • Novartis Capital Increase
  • Intercell - Initial Public Offering
  • Intercell - Second Public Offering
  • for Beginners
  • for Vaccperts
  • for Investors
  • for Careers

EUR 33.0 million Convertible Note 2011

On February 23, 2011 Intercell announced the successful placement of EUR 33.0 of Senior Unsecured Convertible Notes in a private placement transaction.

The terms & conditions and the publications in connection with the Convertible Notes can be downloaded from here:

  • Intercell Completes Placement of EUR 33.0m Senior Convertible Debt Financing (.pdf, 174kB)
  • Summary of Terms (.pdf, 112kB)
  • Report of the Management Board (.pdf, 226kB)
  • Full Terms & Conditions (.pdf, 322 kB)
  • Convertible Bonds - Publications
 
  • CONTACT:
  • AEB:
  • IMPRESSUM/DISCLAIMER